Onco Myx Therapeutics
Pharmaceuticals, 445 North 5th St, Phoenix, Arizona, 85004, United States, 11-50 Employees
Phone Number: 60********
Who is ONCOMYX THERAPEUTICS
OncoMyx Therapeutics targets hematologic and solid tumors with unique oncolytic virus called myxoma (MYXV) and a novel patented systemic delivery approach. The myxoma program is the resul...
Read More
-
Headquarters: 445 North 5th St, Phoenix, Arizona, 85004, United States
-
Date Founded: 2018
-
Employees: 11-50
-
Revenue: $1 Million to $5 Million
-
Active Tech Stack: See technologies
Industry: Pharmaceuticals
SIC Code: 8731
Does something look wrong? Fix it. | View contact records from ONCOMYX THERAPEUTICS
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding OncoMyx Therapeutics
Answer: OncoMyx Therapeutics's headquarters are located at 445 North 5th St, Phoenix, Arizona, 85004, United States
Answer: OncoMyx Therapeutics's phone number is 60********
Answer: OncoMyx Therapeutics's official website is https://oncomyx.com
Answer: OncoMyx Therapeutics's revenue is $1 Million to $5 Million
Answer: OncoMyx Therapeutics's SIC: 8731
Answer: OncoMyx Therapeutics has 11-50 employees
Answer: OncoMyx Therapeutics is in Pharmaceuticals
Answer: OncoMyx Therapeutics contact info: Phone number: 60******** Website: https://oncomyx.com
Answer: OncoMyx Therapeutics targets hematologic and solid tumors with unique oncolytic virus called myxoma (MYXV) and a novel patented systemic delivery approach. The myxoma program is the result of two decades of oncolytic virus research in the laboratory of Professor Grant McFadden. Myxoma is a pox virus that is highly immunostimulatory, and is non-pathogenic in any organism outside of rabbits. The virus has a unique ability to be carried systemically by human leukocytes where it can then infect tumor cells. Programs are in development for both hematology (myeloma and AML) as well as solid tumors. Professor McFadden sequenced the myxoma virus genome in 1999, and since then has produced dozens of genetically engineered constructs, demonstrating its ability as an oncolytic agent across many tumors in preclinical cell and animal models.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month